12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, health care stocks saw significant movements. Molina Healthcare led the gainers with a 24.2% increase, while Spruce Biosciences experienced the largest drop, declining by 75.2%. Other notable movers include Evoke Pharma, Aptorum Gr, and Galecto on the gainers' side, and Qilian Intl Hldg Gr, NuCana, and Regencell Bioscience among the losers.
March 13, 2024 | 9:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aptorum Gr's stock increased by 11.75% to $4.84, indicating investor confidence.
The rise in Aptorum Gr's stock price after hours suggests positive sentiment among investors, possibly due to favorable news or financials. This could contribute to short-term upward movement.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Evoke Pharma's shares rose by 18.54% to $0.76, reflecting a positive market response.
Evoke Pharma's after-market rise suggests investor optimism, potentially due to positive developments within the company. This could lead to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Galecto's shares increased by 10.49% to $0.83, showing a positive trend in investor sentiment.
Galecto's after-market gain reflects growing investor optimism, potentially due to encouraging company developments. This could lead to further short-term gains.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Molina Healthcare's stock surged 24.2% in after-market trading, reaching $503.11 with a market cap of $29.3 billion.
The significant after-market gain for Molina Healthcare suggests positive investor sentiment, potentially due to favorable company news or strong financial performance. This could lead to short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Spruce Biosciences' stock plummeted by 75.2% to $1.29, marking a significant downturn in its market value.
The drastic decline in Spruce Biosciences' stock price indicates a negative market reaction, possibly due to disappointing company news or financial results. This is likely to exert downward pressure on the stock in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100